This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Investigators from multiple institutions conducted a prospective cohort study to assess neurodevelopmental outcomes of children exposed to neonatal hypoglycemia. Children born at ≥32 weeks’ gestation with ≥1 risk factor for neonatal hypoglycemia (diabetic mother, <37 weeks’ gestation, small for gestational age [<10th percentile or <2,500 g], large for gestational age [>90th percentile or >4,500 g], acute illness) were eligible. Enrolled infants had intermittent whole-blood glucose levels measured per a clinical protocol or underwent continuous interstitial glucose monitoring for ≤7 days. Blood glucose concentrations of <47 mg/dL (<2.61 mmol/L) were treated with additional feeding or buccal or intravenous dextrose.
The primary exposure was hypoglycemia, defined as ≥1 episode of blood glucose concentration of <47 mg/dL (<2.61 mmol/L) or a continuous glucose concentration of <47 mg/dL (<2.61 mmol/L) for ≥10 minutes within the first week of …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.